DERMEDIC Jacek Zdybski
- Address
- Sienkiewicza 65/14/II, 27-400 Ostrowiec Świętokrzyski, Poland
Skin and Connective Tissue Diseases
Research at DERMEDIC Jacek Zdybski concentrates on children with moderate-to-severe atopic dermatitis, testing the oral agent abrocitinib to improve outcomes.
- Evaluation of efficacy when combined with standard topical therapy
- Assessment of long‑term safety in young patients
- Exploration of treatment benefits for ages 2‑12 years
- Insights into disease control and quality of life improvements
The site in Ostrowiec Świętokrzyski, Poland has conducted two pediatric trials under a single investigator, reflecting a focused commitment to advancing care for skin disorders without commercial sponsorship.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Pfizer Inc.2active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in DERMEDIC Jacek Zdybski
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Absorption, Systemic Pharmacokinetics, and HPA Axis Suppression of Topical IDP-118 Lotion in Pediatric Moderate to Severe Plaque Psoriasis | Bausch Health Americas Inc. | Phase II | Not Recruiting | Mar 2021 | Nov 2025 |
IMP list
lock Showing 1 of 3 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Abrocitinib | 2 | Unknown | 2025-09-30 | 2025-12-19 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.